Medicina Clinica最新文献

筛选
英文 中文
Acute organophosphorus pesticide poisoning with hepatic portal venous gas 急性有机磷农药中毒伴肝门静脉气体
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-23 DOI: 10.1016/j.medcli.2025.106967
Xinsen Chen , Ting Jiang , Lu Zhang
{"title":"Acute organophosphorus pesticide poisoning with hepatic portal venous gas","authors":"Xinsen Chen , Ting Jiang , Lu Zhang","doi":"10.1016/j.medcli.2025.106967","DOIUrl":"10.1016/j.medcli.2025.106967","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 3","pages":"Article 106967"},"PeriodicalIF":2.6,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144115882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of blood coagulation index in obstetric antiphospholipid syndrome and its subtypes 凝血指标对产科抗磷脂综合征及其亚型的诊断价值
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106997
Xuan Qi , Xiaomeng Li , Yan Han , Lingyan Lei , Huifang Guo
{"title":"Diagnostic value of blood coagulation index in obstetric antiphospholipid syndrome and its subtypes","authors":"Xuan Qi ,&nbsp;Xiaomeng Li ,&nbsp;Yan Han ,&nbsp;Lingyan Lei ,&nbsp;Huifang Guo","doi":"10.1016/j.medcli.2025.106997","DOIUrl":"10.1016/j.medcli.2025.106997","url":null,"abstract":"<div><h3>Objective</h3><div>To characterize blood coagulation index in obstetric antiphospholipid syndrome (OAPS) and its subtypes, analyzing correlations with immunological indices and diagnostic value.</div></div><div><h3>Methods</h3><div>A retrospective analysis was performed on OAPS patients treated at the Department of Rheumatology and Immunology, Second Hospital of Hebei Medical University, from September 2023 to March 2024. Healthy women of the same age range were matched for comparison.</div></div><div><h3>Results</h3><div>A total of 102 OAPS patients and 80 matched healthy controls were included. OAPS patients exhibited significantly lower levels of complement factors C3 and C4, coagulation factors V and VII activities, and protein S activity (<em>p</em> <!-->&lt;<!--> <!-->0.05). Conversely, they had elevated levels of anti-β2 glycoprotein I antibodies, platelets, thrombin–antithrombin complex (TAT), thromboelastographic reaction time (R), maximum amplitude (MA), clot formation index (CI), von Willebrand factor activity, coagulation factor VIII activity, and activated partial thromboplastin time (APTT) (<em>p</em> <!-->&lt;<!--> <!-->0.05). Among OAPS patients, criteria OAPS cases showed significantly higher anti-β2-GPI antibodies and anticardiolipin antibody levels (<em>p</em> <!-->&lt;<!--> <!-->0.01), with more spontaneous abortions and fetal deaths in this group (<em>p</em> <!-->&lt;<!--> <!-->0.01).</div></div><div><h3>Conclusion</h3><div>Correlations were found between immunological indices (ANA, complement C3, anti-β2-GPI) and coagulation indices (TAT, APTT). ANA, complement C3, anti-β2-GPI antibodies, and TAT were identified as risk factors for predicting OAPS. Blood coagulation and immune indices correlate in OAPS. Detecting these indices may provide diagnostic value for OAPS and its subtypes.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 1","pages":"Article 106997"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relapsing polychondritis 复发polychondritis
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106985
Makram Tbini , Ines Riahi , Chaima Ben Ammar , Mamia Ben Salah
{"title":"Relapsing polychondritis","authors":"Makram Tbini ,&nbsp;Ines Riahi ,&nbsp;Chaima Ben Ammar ,&nbsp;Mamia Ben Salah","doi":"10.1016/j.medcli.2025.106985","DOIUrl":"10.1016/j.medcli.2025.106985","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 2","pages":"Article 106985"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whipple's disease mimicking systemic lupus erythematosus 类似系统性红斑狼疮的惠普尔氏病
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106960
Laia de Daniel , Xavier Sanjuan , Javier Narváez
{"title":"Whipple's disease mimicking systemic lupus erythematosus","authors":"Laia de Daniel ,&nbsp;Xavier Sanjuan ,&nbsp;Javier Narváez","doi":"10.1016/j.medcli.2025.106960","DOIUrl":"10.1016/j.medcli.2025.106960","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 1","pages":"Article 106960"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144105398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal hemoptysis due to massive cavitation of lung metastases in a patient with adenoid cystic carcinoma treated with lenvatinib 在lenvatinib治疗的腺样囊性癌患者中,由于肺转移的大量空化而致致命性咯血
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106955
Luis Gorospe , Yolanda Lage-Alfranca , Ainara Soria-Rivas , Abel González-Huete
{"title":"Fatal hemoptysis due to massive cavitation of lung metastases in a patient with adenoid cystic carcinoma treated with lenvatinib","authors":"Luis Gorospe ,&nbsp;Yolanda Lage-Alfranca ,&nbsp;Ainara Soria-Rivas ,&nbsp;Abel González-Huete","doi":"10.1016/j.medcli.2025.106955","DOIUrl":"10.1016/j.medcli.2025.106955","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 3","pages":"Article 106955"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico 亚临床血管疾病的患病率与估计的血管风险和代谢综合征的存在有关
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106987
José María Mostaza , Carlos Lahoz , Miguel A. Salinero-Fort , Eva Estirado , Francisca García-Iglesias , Teresa González Alegre , Víctor Cornejo , en representación de los investigadores del estudio ESPREDIA
{"title":"Prevalencia de enfermedad vascular subclínica en función del riesgo vascular estimado y la presencia de síndrome metabólico","authors":"José María Mostaza ,&nbsp;Carlos Lahoz ,&nbsp;Miguel A. Salinero-Fort ,&nbsp;Eva Estirado ,&nbsp;Francisca García-Iglesias ,&nbsp;Teresa González Alegre ,&nbsp;Víctor Cornejo ,&nbsp;en representación de los investigadores del estudio ESPREDIA","doi":"10.1016/j.medcli.2025.106987","DOIUrl":"10.1016/j.medcli.2025.106987","url":null,"abstract":"<div><div>Most vascular complications occur in persons with a low or moderate calculated vascular risk. We have evaluated the added prediction of the metabolic syndrome (MS) to the presence of subclinical vascular disease (SVD), beyond that estimated by the cardiovascular risk calculation.</div></div><div><h3>Patients and methods</h3><div>Cross-sectional population-based study, in 1,061 subjects aged 45 to 75 years, without diabetes or known vascular disease, randomly selected from the Primary Care registries of Madrid (Spain). Vascular risk was calculated using SCORE2 and SCORE2-OP, the presence of MS was determined, and the prevalence of SVD was established by quantification of carotid plaques and ankle-brachial index.</div></div><div><h3>Results</h3><div>Of the included population, 40.2% was at low/moderate risk, 54.5% at high risk and 5.3% at very high risk. A total of 36.1% met the criteria for MS. The prevalence of SVD was 27.7, 50.1 and 71.4% in subjects at low/moderate, high and very high risk without MS, and 42.5, 62.6 and 78.6% if they had MS, respectively. The association of MS with the presence of EVS was independent of its separate components. A total of 23.1% of the participants were receiving statin treatment. Statin use was independent of the calculated cardiovascular risk and much higher in subjects with MS (38.6 vs. 12.8%).</div></div><div><h3>Conclusion</h3><div>Subjects with MS have a high prevalence of SVD, independent of the estimated risk. The use of statins is more prevalent in subjects with the MS, and is independent of the estimated cardiovascular risk.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 2","pages":"Article 106987"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platypnea-orthodeoxia syndrome in an elderly patient with undiagnosed patent foramen ovale 未确诊卵圆孔未闭的老年患者肺动脉-正氧综合征1例
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.107008
Francisco Epelde
{"title":"Platypnea-orthodeoxia syndrome in an elderly patient with undiagnosed patent foramen ovale","authors":"Francisco Epelde","doi":"10.1016/j.medcli.2025.107008","DOIUrl":"10.1016/j.medcli.2025.107008","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 2","pages":"Article 107008"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efectividad de la timectomía en la evolución de la miastenia gravis: análisis de 21 pacientes 乳房切除术对重症肌无力发展的影响:分析21例患者
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106957
Sofía Corbaz , Andrea Savransky , Nadia Gaeto , Adolfo Gallo , Marcelo Barrenechea , María Soledad Monges
{"title":"Efectividad de la timectomía en la evolución de la miastenia gravis: análisis de 21 pacientes","authors":"Sofía Corbaz ,&nbsp;Andrea Savransky ,&nbsp;Nadia Gaeto ,&nbsp;Adolfo Gallo ,&nbsp;Marcelo Barrenechea ,&nbsp;María Soledad Monges","doi":"10.1016/j.medcli.2025.106957","DOIUrl":"10.1016/j.medcli.2025.106957","url":null,"abstract":"<div><h3>Introduction</h3><div>Myasthenia gravis is part of a group of neuromuscular junction disorders. Thymectomy has been shown to be effective for its clinical control. The aim of this study was to assess the usefulness and safety of thymectomy in children with myasthenia gravis.</div></div><div><h3>Methods</h3><div>An analytical, retrospective, longitudinal study was conducted by reviewing the medical records of 21 patients with myasthenia gravis who underwent thymectomy and were followed-up for one year post-surgery. The variables assessed included the Myasthenia Gravis Activities of Daily Living score, pyridostigmine dose, corticosteroid dose, and myasthenia gravis exacerbations immediately before and up to one year after the surgery.</div></div><div><h3>Results</h3><div>The activities of daily living score significantly improved at 12 months (p<!--> <!-->=<!--> <!-->0.002). Crises decreased within 3 months post-surgery; this trend was maintained at 12 months (p<!--> <!-->=<!--> <!-->0.0003). However, the reductions in pyridostigmine (p<!--> <!-->=<!--> <!-->0.147) and corticosteroid therapy (p<!--> <!-->=<!--> <!-->0.11) at 12 months did not reach statistical significance.</div></div><div><h3>Conclusions</h3><div>Thymectomy showed benefits, including improved scores on the Myasthenia Gravis Activities of Daily Living Scale and a reduction in the frequency of myasthenia gravis exacerbations/crises. These findings show that thymectomy is a safe and valid option to consider for pediatric patients who have not responded to the first-line treatment.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 2","pages":"Article 106957"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144114967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori y enfermedad gástrica 幽门螺杆菌gástrica
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106974
Javier P. Gisbert
{"title":"Helicobacter pylori y enfermedad gástrica","authors":"Javier P. Gisbert","doi":"10.1016/j.medcli.2025.106974","DOIUrl":"10.1016/j.medcli.2025.106974","url":null,"abstract":"<div><div>The infection caused by <em>Helicobacter pylori</em> is the most common on the planet, affecting half of the global population. It is usually transmitted during childhood and persists for life if untreated. It is the primary cause of chronic gastritis, peptic ulcer, and gastric cancer. In young dyspeptic patients without alarm symptoms, the test-and-treat strategy (detection of <em>H. pylori</em> through a non-invasive test and subsequent eradication) is the preferred approach. The causal role of the infection in the development of gastric adenocarcinoma provides an opportunity to implement preventive strategies. The infection can be diagnosed through invasive methods (requiring endoscopy, such as the rapid urease test or histology) and non-invasive methods (such as the breath test or stool antigen test). The treatment for <em>H. pylori</em> combines a proton pump inhibitor with several antibiotics or bismuth salts.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 1","pages":"Article 106974"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144106009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diferencias en el perfil clínico entre hombres y mujeres con apneas obstructivas del sueño 男性和女性阻塞性睡眠呼吸暂停患者的临床情况差异
IF 2.6 4区 医学
Medicina Clinica Pub Date : 2025-05-22 DOI: 10.1016/j.medcli.2025.106975
Nuria Roger-Casals , Ana Maria Muñoz-Fernández , Cristina Muñoz-Pindado
{"title":"Diferencias en el perfil clínico entre hombres y mujeres con apneas obstructivas del sueño","authors":"Nuria Roger-Casals ,&nbsp;Ana Maria Muñoz-Fernández ,&nbsp;Cristina Muñoz-Pindado","doi":"10.1016/j.medcli.2025.106975","DOIUrl":"10.1016/j.medcli.2025.106975","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"165 1","pages":"Article 106975"},"PeriodicalIF":2.6,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144116871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信